Cargando…

Brain imaging measurements of fibrillar amyloid‐β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele

INTRODUCTION: We previously characterized associations between brain imaging measurements of amyloid‐β (Aβ) plaque burden and apolipoprotein E (APOE ) ε4 gene dose in a small number of cognitively unimpaired late‐middle‐aged APOE ε4 homozygotes (HMs), heterozygotes (HTs), and noncarriers (NCs). We n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghisays, Valentina, Goradia, Dhruman D., Protas, Hillary, Bauer, Robert J., Devadas, Vivek, Tariot, Pierre N., Lowe, Val J., Knopman, David S., Petersen, Ronald C., Jack, Clifford R., Caselli, Richard J., Su, Yi, Chen, Kewei, Reiman, Eric M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187298/ https://www.ncbi.nlm.nih.gov/pubmed/31831374 http://dx.doi.org/10.1016/j.jalz.2019.08.195

Ejemplares similares

Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults
por: Malek-Ahmadi, Michael, et al.
Publicado: (2023)

Individualized network analysis: A novel approach to investigate tau PET using graph theory in the Alzheimer’s disease continuum
por: Protas, Hillary, et al.
Publicado: (2023)

Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
por: Nielsen, Henrietta M., et al.
Publicado: (2017)

Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
por: Edlund, Anna K., et al.
Publicado: (2021)

Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects
por: Dong, Qunxi, et al.
Publicado: (2019)

Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers
por: Elahi, Fanny M., et al.
Publicado: (2021)

Association between an Alzheimer’s Disease-Related Index and APOE ε4 Gene Dose
por: Schraml, Frank, et al.
Publicado: (2013)

Memory precision of object-location binding is unimpaired in APOE ε4-carriers with spatial navigation deficits
por: Gellersen, Helena M, et al.
Publicado: (2021)

The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals
por: Salvadó, Gemma, et al.
Publicado: (2021)

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
por: Snellman, Anniina, et al.
Publicado: (2023)

APOE ϵ4 modifies the relationship between infectious burden and poor cognition
por: Zhao, Chen, et al.
Publicado: (2020)

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
por: Ghisays, Valentina, et al.
Publicado: (2021)

APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
por: Brugulat-Serrat, Anna, et al.
Publicado: (2023)

Applying surface-based morphometry to study ventricular abnormalities of cognitively unimpaired subjects prior to clinically significant memory decline
por: Dong, Qunxi, et al.
Publicado: (2020)

THE RELATIONSHIP OF APOE ε4 TO THE RELATIVE TIMES AND HAZARDS OF DEMENTIA
por: Powell, Danielle, et al.
Publicado: (2019)

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
por: Rios‐Romenets, Silvia, et al.
Publicado: (2020)

Quantitative informant‐ and self‐reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4
por: Sánchez‐Benavides, Gonzalo, et al.
Publicado: (2020)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

Effect of BDNF Val66Met on hippocampal subfields volumes and compensatory interaction with APOE-ε4 in middle-age cognitively unimpaired individuals from the ALFA study
por: Vilor-Tejedor, Natalia, et al.
Publicado: (2020)

The Relationship of APOE ε4, Race, and Sex on the Age of Onset and Risk of Dementia
por: Powell, Danielle S., et al.
Publicado: (2021)

Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts
por: Cacciaglia, Raffaele, et al.
Publicado: (2022)

Default Mode Network Analysis of APOE Genotype in Cognitively Unimpaired Subjects Based on Persistent Homology
por: Kuang, Liqun, et al.
Publicado: (2020)

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
por: Chen, Kewei, et al.
Publicado: (2012)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Longitudinal white matter and cognitive development in pediatric carriers of the apolipoprotein ε4 allele
por: Remer, Justin, et al.
Publicado: (2020)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
por: Walker, Rosie M., et al.
Publicado: (2021)

Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele
por: Roberts, Rosebud O., et al.
Publicado: (2015)

APOE ε2 is associated with increased tau pathology in primary tauopathy
por: Zhao, Na, et al.
Publicado: (2018)

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile
por: Milà-Alomà, Marta, et al.
Publicado: (2021)

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
por: Zokaei, Nahid, et al.
Publicado: (2017)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
por: Porter, Tenielle, et al.
Publicado: (2018)

Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer’s Prevention Trial: A global Perspective from the API Generation Program
por: Walsh, T., et al.
Publicado: (2023)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
por: López-García, Sara, et al.
Publicado: (2021)

Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
por: Salvadó, Gemma, et al.
Publicado: (2021)

LDL cholesterol is associated with higher AD neuropathology burden independent of APOE
por: Wingo, Aliza P, et al.
Publicado: (2022)

Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
por: Huentelman, Matt, et al.
Publicado: (2019)

Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer’s disease
por: Caputo, Angelika, et al.
Publicado: (2023)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration
por: Su, Wen-Hua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eslsmt11fa9g85e84p6ds1cfmm